Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110363313> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2110363313 abstract "To determine the relationship between pretreatment serum squamous cell carcinoma (SCC) antigen and Cyfra 21-1 levels, and survival in patients with invasive squamous cell carcinoma of the cervix.One hundred and one cervical squamous cell carcinoma patients were included. Pre-treatment levels of serum SCC antigen and Cyfra 21-1 were measured, with a 5 year minimum follow up. Thirty two recurrent disease (RD) patients were compared to 99 non-recurrent disease (NRD) patients with respect to tumor markers, FIGO stage, lesion size, lymph node status, and parametrial involvement.Pre-treatment serum SCC antigen and Cyfra 21-1 levels were significantly higher in the RD group (p<0.001). Combined serum SCC antigen and Cyfra 21-1 levels showed higher sensitivity for prediction of recurrence (90.6%). Pre-treatment SCC antigen and Cyfra 21-1 levels showed correlation with high FIGO stage, large lesion size, lymph node status, and parametrial involvement (p<0.001). Normal pre-treatment levels of SCC antigen and Cyfra 21-1 showed a 5-year survival rate of 93% and 90% respectively, while elevated levels showed significantly decreased survival rate of 63% and 59%, respectively (p<0.001). Odd ratio for cumulative survival rates were 6.87 for SCC antigen, and 5.07 for Cyfra 21-1 (p<0.001).Initial pre-treatment levels of serum SCC antigen and Cyfra 21-1 are closely related to FIGO stage, lesion size, lymph node and parametrial involvement in patients with squamous cell carcinoma of the cervix. Also, these markers may be of help to predicting recurrent disease and survival rates." @default.
- W2110363313 created "2016-06-24" @default.
- W2110363313 creator A5009862143 @default.
- W2110363313 creator A5030481456 @default.
- W2110363313 creator A5051523705 @default.
- W2110363313 creator A5052768774 @default.
- W2110363313 creator A5060233803 @default.
- W2110363313 date "2005-01-01" @default.
- W2110363313 modified "2023-09-24" @default.
- W2110363313 title "Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix" @default.
- W2110363313 cites W1955145617 @default.
- W2110363313 cites W1973871550 @default.
- W2110363313 cites W1981936227 @default.
- W2110363313 cites W1987851799 @default.
- W2110363313 cites W2006184491 @default.
- W2110363313 cites W2011904133 @default.
- W2110363313 cites W2024113002 @default.
- W2110363313 cites W2069851999 @default.
- W2110363313 cites W2073660691 @default.
- W2110363313 cites W2074146726 @default.
- W2110363313 cites W2074433861 @default.
- W2110363313 cites W2090738534 @default.
- W2110363313 cites W2140134094 @default.
- W2110363313 cites W2142719896 @default.
- W2110363313 doi "https://doi.org/10.4143/crt.2005.37.5.302" @default.
- W2110363313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2785931" @default.
- W2110363313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19956531" @default.
- W2110363313 hasPublicationYear "2005" @default.
- W2110363313 type Work @default.
- W2110363313 sameAs 2110363313 @default.
- W2110363313 citedByCount "0" @default.
- W2110363313 crossrefType "journal-article" @default.
- W2110363313 hasAuthorship W2110363313A5009862143 @default.
- W2110363313 hasAuthorship W2110363313A5030481456 @default.
- W2110363313 hasAuthorship W2110363313A5051523705 @default.
- W2110363313 hasAuthorship W2110363313A5052768774 @default.
- W2110363313 hasAuthorship W2110363313A5060233803 @default.
- W2110363313 hasBestOaLocation W21103633132 @default.
- W2110363313 hasConcept C121608353 @default.
- W2110363313 hasConcept C126322002 @default.
- W2110363313 hasConcept C142724271 @default.
- W2110363313 hasConcept C143998085 @default.
- W2110363313 hasConcept C147483822 @default.
- W2110363313 hasConcept C203014093 @default.
- W2110363313 hasConcept C2777546739 @default.
- W2110363313 hasConcept C2777740455 @default.
- W2110363313 hasConcept C2992879611 @default.
- W2110363313 hasConcept C3019992690 @default.
- W2110363313 hasConcept C502942594 @default.
- W2110363313 hasConcept C71924100 @default.
- W2110363313 hasConceptScore W2110363313C121608353 @default.
- W2110363313 hasConceptScore W2110363313C126322002 @default.
- W2110363313 hasConceptScore W2110363313C142724271 @default.
- W2110363313 hasConceptScore W2110363313C143998085 @default.
- W2110363313 hasConceptScore W2110363313C147483822 @default.
- W2110363313 hasConceptScore W2110363313C203014093 @default.
- W2110363313 hasConceptScore W2110363313C2777546739 @default.
- W2110363313 hasConceptScore W2110363313C2777740455 @default.
- W2110363313 hasConceptScore W2110363313C2992879611 @default.
- W2110363313 hasConceptScore W2110363313C3019992690 @default.
- W2110363313 hasConceptScore W2110363313C502942594 @default.
- W2110363313 hasConceptScore W2110363313C71924100 @default.
- W2110363313 hasLocation W21103633131 @default.
- W2110363313 hasLocation W21103633132 @default.
- W2110363313 hasLocation W21103633133 @default.
- W2110363313 hasLocation W21103633134 @default.
- W2110363313 hasOpenAccess W2110363313 @default.
- W2110363313 hasPrimaryLocation W21103633131 @default.
- W2110363313 hasRelatedWork W2017797747 @default.
- W2110363313 hasRelatedWork W2024472469 @default.
- W2110363313 hasRelatedWork W2329500120 @default.
- W2110363313 hasRelatedWork W2364092196 @default.
- W2110363313 hasRelatedWork W2394943688 @default.
- W2110363313 hasRelatedWork W2411326645 @default.
- W2110363313 hasRelatedWork W2416519695 @default.
- W2110363313 hasRelatedWork W2435342977 @default.
- W2110363313 hasRelatedWork W2442039146 @default.
- W2110363313 hasRelatedWork W2469611016 @default.
- W2110363313 isParatext "false" @default.
- W2110363313 isRetracted "false" @default.
- W2110363313 magId "2110363313" @default.
- W2110363313 workType "article" @default.